Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice

IR Dunay, K Gajurel, R Dhakal… - Clinical microbiology …, 2018 - Am Soc Microbiol
Primary Toxoplasma gondii infection is usually subclinical, but cervical lymphadenopathy or
ocular disease can be present in some patients. Active infection is characterized by …

Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis

C Cifuentes-González, W Rojas-Carabali, ÁO Pérez… - PloS one, 2023 - journals.plos.org
Background Ocular toxoplasmosis (OT) is caused by the parasite Toxoplasma gondii. OT is
the leading cause of posterior uveitis globally; it is a recurrent disease that may result in …

An eye for azithromycin: review of the literature

KA Kagkelaris, OE Makri… - Therapeutic …, 2018 - journals.sagepub.com
Azithromycin is used widely in clinical practice and recently it is available in topical solution
for ophthalmic use. The purpose of the current publication is to summarize the newest …

Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis

Y Zhang, X Lin, F Lu - Acta tropica, 2018 - Elsevier
Ocular toxoplasmosis (OT) is the most frequent form of infectious posterior uveitis caused by
the protozoan parasite Toxoplasma gondii. To evaluate the available evidence in peer …

Treatment strategy in human ocular toxoplasmosis: Why antibiotics have failed

JG Garweg, U Pleyer - Journal of clinical medicine, 2021 - mdpi.com
Background: There is currently no clear evidence of the effectiveness of antibiotic therapy in
acute ocular toxoplasmosis (OT), but its effect as a secondary prophylaxis is undisputed. The …

Ocular toxoplasmosis

EJH Goh, I Putera, R La Distia Nora… - Ocular Immunology …, 2023 - Taylor & Francis
Introduction: Ocular toxoplasmosis is the leading cause of posterior uveitis worldwide,
affecting individuals acrossdifferent age groups. The key to reducing vision loss includes …

COVID-19: potential therapeutics for pediatric patients

NK Younis, RO Zareef, G Fakhri, F Bitar, AH Eid… - Pharmacological …, 2021 - Springer
The global spread of COVID-19 has imparted significant economic, medical, and social
burdens. Like adults, children are affected by this pandemic. However, milder clinical …

Toxoplasma gondii and human immunodeficiency virus co-infection in western Iran: A cross sectional study

N Nazari, A Bozorgomid, A Janbakhsh… - Asian Pacific Journal of …, 2018 - journals.lww.com
Objective: To determine Toxoplasma gondii (T. gondii) as a cause of morbidity and mortality
in human immunodeficiency virus (HIV) infected patients by ELISA method and to …

Considerations in the management of ocular toxoplasmosis in pregnancy: a review of literature

JCM Artiaga, CP Azarcon, FD Levina, AJ Bromeo… - Eye, 2024 - nature.com
Ocular toxoplasmosis is the most common cause of infectious posterior uveitis. Available
literature is still conflicting regarding the incidence of recurrence during pregnancy as …

Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis

JE Feliciano-Alfonso, J Muñoz-Ortiz… - Systematic …, 2021 - Springer
Background Ocular toxoplasmosis (OT) is the most common cause of posterior uveitis, which
leads to visual impairment in a large proportion of patients. Antibiotics and corticosteroids …